findmyKOL
Clinical trialNCT01583816CompletedPhase 2Interventional

Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions

SponsorSpirig Pharma Ltd.Enrollment218Actinic Keratosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Hauttumorcentrum Charité (htcc)

    Berlin, Germany

  • Medizinisches Zentrum Bonn - Friedensplatz

    Bonn, Germany

  • Hautzentrum

    Düsseldorf, Germany

  • Johannes Wesling Klinikum Minden

    Minden, Germany

  • Klinikum Vest Gmbh Knappschaftskrankenhaus

    Recklinghausen, Germany

Switzerland
  • Kantonsspital Aarau

    Aarau, Switzerland

  • Universitätsspital Basel

    Basel, Switzerland

  • Inselspital

    Bern, Switzerland

  • Kantonsspital St.Gallen

    Sankt Gallen, Switzerland

  • Universitaetsspital Zurich

    Zurich, Switzerland

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2012
Primary completion
30 Nov 2013
Completion
30 Jun 2014
Last update posted
15 Dec 2015
Registered enrollment
218
Registry id
NCT01583816

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.